Yadollah Poornajaf

Interaction Between Non-Coding RNAs and Interferons: With an Especial Focus on Type I Interferons

M. Taheri, S. Ghafouri-Fard, E. Jamali, 2022, Frontiers in Immunology.

Interactions between non-coding RNAs and HIF-1α in the context of cancer.

M. Taheri, S. Ghafouri-Fard, B. Hussen, 2023, European journal of pharmacology.

Implication of non-coding RNA-mediated ROCK1 regulation in various diseases

M. Taheri, S. Ghafouri-Fard, G. Sharifi, 2022, Frontiers in Molecular Biosciences.

Deciphering the role of Hippo pathway in lung cancer

M. Taheri, S. Ghafouri-Fard, M. Mokhtari, 2023, Pathology - Research and Practice.

NLRP3: Role in ischemia/reperfusion injuries

M. Taheri, S. Ghafouri-Fard, Atefe Abak, 2022, Frontiers in Immunology.

Interplay between programmed death-ligand 1 and non-coding RNAs

M. Taheri, S. Ghafouri-Fard, G. Sharifi, 2022, Frontiers in Immunology.

Emerging functions and clinical applications of exosomal microRNAs in diseases

P. Dong, M. Taheri, S. Ghafouri-Fard, 2023, Non-coding RNA research.

Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance.

Forough Alemi, H. Shoorei, Yadollah Poornajaf, 2024, Molecular biology reports.